ArticleThe Lancet regional health. Europe2026

Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind.

Elamin Abdelgadir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.